Skip to main content

TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Abstract to Be Presented Next Month at ASCO Annual Meeting

Predictive Oncology (NASDAQ: POAI), a leader in artificial-intelligence (“AI”)-driven drug discovery and biologics, announced that its abstract has been accepted for presentation at the upcoming American Society of Clinical Oncology (“ASCO”) annual meeting. This year’s meeting is slated for May 31–June 4, 2024, in Chicago. According to the company, the abstract contains data and results gathered from a recent study completed through a collaboration between Predictive Oncology and UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania. The company observed that the study was designed to evaluate whether multiomic machine-learning models could be used to better predict short- and long-term survival outcomes for women diagnosed with high grade serous ovarian cancer (“HGSC”) as compared to clinical data alone. Titled Using Artificial Intelligence-Powered Evidence-Based Molecular Decision-Making for Improved Outcomes in Ovarian Cancer,” the abstract will be presented during the gynecologic cancer session on June 3, 2024, from 10 a.m.–1 p.m. ET. Dr. Brian Christopher Orr, MD, MS, will present the abstract. Orr is a gynecologic oncologist at the Hollings Cancer Center and an assistant professor at the Medical University of South Carolina.

To view the full press release, visit

About TinyGems

TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published:

Los Angeles, CA
310.299.1717 Office

TinyGems is powered by IBN

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.